Literature DB >> 29606312

Transport Barriers and Oncophysics in Cancer Treatment.

Sara Nizzero1, Arturas Ziemys2, Mauro Ferrari3.   

Abstract

Transport processes in cancer are the focus of transport oncophysics (TOP). In the TOP approach, the sequential negotiation of transport barriers is critical to both drug delivery and metastasis development. New and creative therapeutic opportunities are currently emerging, stimulated by the study of cancer hallmarks with the TOP approach.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  biophysical markers; drug partitioning; drug transport; transport barriers; transport oncophysics; transport phenotype

Mesh：

Substances：

Year:  2018        PMID： 29606312      PMCID： PMC6441955          DOI： 10.1016/j.trecan.2018.02.008

Source DB:  PubMed          Journal:  Trends Cancer        ISSN： 2405-8025


  11 in total

Review 1.  Nanotechnology and Immunotherapy in Ovarian Cancer: Tracing New Landscapes.

Authors:  Bruna Corradetti; Simone Pisano; Robert Steven Conlan; Mauro Ferrari
Journal:  J Pharmacol Exp Ther       Date:  2019-02-08       Impact factor: 4.030

Review 2.  An Updated Review on EPR-Based Solid Tumor Targeting Nanocarriers for Cancer Treatment.

Authors:  Majid Sharifi; William C Cho; Asal Ansariesfahani; Rahil Tarharoudi; Hedyeh Malekisarvar; Soyar Sari; Samir Haj Bloukh; Zehra Edis; Mohamadreza Amin; Jason P Gleghorn; Timo L M Ten Hagen; Mojtaba Falahati
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

3.  Extension of a multiphase tumour growth model to study nanoparticle delivery to solid tumours.

Authors:  Barbara Wirthl; Johannes Kremheller; Bernhard A Schrefler; Wolfgang A Wall
Journal:  PLoS One       Date:  2020-02-05       Impact factor: 3.240

4.  Therapeutic Dose Response of Acoustic Cluster Therapy in Combination With Irinotecan for the Treatment of Human Colon Cancer in Mice.

Authors:  Nigel Bush; Andrew Healey; Anant Shah; Gary Box; Vladimir Kirkin; Spiros Kotopoulis; Svein Kvåle; Per Christian Sontum; Jeffrey Bamber
Journal:  Front Pharmacol       Date:  2019-11-19       Impact factor: 5.810

Review 5.  Image-guided mathematical modeling for pharmacological evaluation of nanomaterials and monoclonal antibodies.

Authors:  Prashant Dogra; Joseph D Butner; Sara Nizzero; Javier Ruiz Ramírez; Achraf Noureddine; María J Peláez; Dalia Elganainy; Zhen Yang; Anh-Dung Le; Shreya Goel; Hon S Leong; Eugene J Koay; C Jeffrey Brinker; Vittorio Cristini; Zhihui Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-04-21

Review 6.  Engineering precision nanoparticles for drug delivery.

Authors:  Michael J Mitchell; Margaret M Billingsley; Rebecca M Haley; Marissa E Wechsler; Nicholas A Peppas; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2020-12-04       Impact factor: 84.694

Review 7.  Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles.

Authors:  Parisa Foroozandeh; Azlan Abdul Aziz
Journal:  Nanoscale Res Lett       Date:  2018-10-25       Impact factor: 4.703

8.  Theranostic Attributes of Acoustic Cluster Therapy and Its Use for Enhancing the Effectiveness of Liposomal Doxorubicin Treatment of Human Triple Negative Breast Cancer in Mice.

Authors:  Nigel Bush; Andrew Healey; Anant Shah; Gary Box; Vladimir Kirkin; Sue Eccles; Per Christian Sontum; Spiros Kotopoulis; Svein Kvåle; Annemieke van Wamel; Catharina de Lange Davies; Jeffrey Bamber
Journal:  Front Pharmacol       Date:  2020-02-20       Impact factor: 5.810

9.  A computational diffusion model to study antibody transport within reconstructed tumor microenvironments.

Authors:  Ana Luísa Cartaxo; Jaime Almeida; Emilio J Gualda; Maria Marsal; Pablo Loza-Alvarez; Catarina Brito; Inês A Isidro
Journal:  BMC Bioinformatics       Date:  2020-11-17       Impact factor: 3.169

10.  SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarcinoma?

Authors:  Spiros Kotopoulis; Mihaela Popa; Mireia Mayoral Safont; Elisa Murvold; Ragnhild Haugse; Anika Langer; Georg Dimcevski; Christina Lam; Tormod Bjånes; Odd Helge Gilja; Emmet Mc Cormack
Journal:  Pharmaceutics       Date:  2022-01-01       Impact factor: 6.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.